Drug Type CAR-T |
Synonyms ORI -C321, ORI C321 |
Target |
Mechanism BCMA modulators(B-cell maturation protein modulators), GPRC5D modulators(G-protein coupled receptor family C group 5member D modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Refractory Multiple Myeloma | Phase 1 | - | 01 Apr 2022 | |
Relapse multiple myeloma | Phase 1 | - | 01 Apr 2022 | |
Multiple Myeloma | IND Application | - | - |